MBX Operating Income from 2010 to 2026

MBX Stock   34.79  2.47  6.63%   
MBX Biosciences Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income will likely drop to about -64.4 M in 2026. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit MBX Biosciences Common generates from its operations. View All Fundamentals
 
Operating Income  
First Reported
2010-12-31
Previous Quarter
-61.4 M
Current Value
-64.4 M
Quarterly Volatility
15.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check MBX Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MBX Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 7.6 M, Interest Income of 7.6 M or Depreciation And Amortization of 167.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.26. MBX financial statements analysis is a perfect complement when working with MBX Biosciences Valuation or Volatility modules.
  
Build AI portfolio with MBX Stock
Check out the analysis of MBX Biosciences Correlation against competitors.
The evolution of Operating Income for MBX Biosciences Common provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how MBX Biosciences compares to historical norms and industry peers.

Latest MBX Biosciences' Operating Income Growth Pattern

Below is the plot of the Operating Income of MBX Biosciences Common over the last few years. Operating Income is the amount of profit realized from MBX Biosciences Common operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of MBX Biosciences Common is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. MBX Biosciences' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MBX Biosciences' overall financial position and show how it may be relating to other accounts over time.
Operating Income10 Years Trend
Slightly volatile
   Operating Income   
       Timeline  

MBX Operating Income Regression Statistics

Arithmetic Mean(32,730,349)
Coefficient Of Variation(47.30)
Mean Deviation11,576,651
Median(25,161,000)
Standard Deviation15,482,595
Sample Variance239.7T
Range43M
R-Value(0.70)
Mean Square Error130.1T
R-Squared0.49
Significance0
Slope(2,148,779)
Total Sum of Squares3835.4T

MBX Operating Income History

2026-64.4 M
2025-61.4 M
2024-68.2 M
2023-35.3 M

About MBX Biosciences Financial Statements

MBX Biosciences investors use historical fundamental indicators, such as MBX Biosciences' Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MBX Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Income-61.4 M-64.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MBX Stock Analysis

When running MBX Biosciences' price analysis, check to measure MBX Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MBX Biosciences is operating at the current time. Most of MBX Biosciences' value examination focuses on studying past and present price action to predict the probability of MBX Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MBX Biosciences' price. Additionally, you may evaluate how the addition of MBX Biosciences to your portfolios can decrease your overall portfolio volatility.